The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:52
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [41] Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy
    Phillips, Alexander W.
    Lagarde, Sjoerd M.
    Navidi, Maziar
    Disep, Babbet
    Griffin, S. Michael
    ANNALS OF SURGERY, 2017, 265 (04) : 750 - 756
  • [42] The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis
    Imai, Takeharu
    Tanaka, Yoshihiro
    Sato, Yuta
    Mase, Junichi
    Suetsugu, Tomonari
    Fukada, Masahiro
    Yasufuku, Itaru
    Iwata, Yoshinori
    Mori, Ryutaro
    Imai, Hisashi
    Kato, Takazumi
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Futamura, Manabu
    Yoshida, Kazuhiro
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (04) : 776 - 784
  • [43] Adjuvant chemotherapy is associated with improved survival in patients with nodal metastases after neoadjuvant therapy and esophagectomy
    Drake, Justin
    Tauer, Kurt
    Portnoy, David
    Weksler, Benny
    JOURNAL OF THORACIC DISEASE, 2019, 11 (06) : 2546 - +
  • [44] How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
    Taniyama, Yusuke
    Sakurai, Tadashi
    Hikage, Makoto
    Okamoto, Hiroshi
    Sato, Chiaki
    Takaya, Kai
    Unno, Michiaki
    Kamei, Takashi
    THORACIC CANCER, 2019, 10 (04) : 769 - 774
  • [45] Esophagectomy after endoscopic submucosal dissection for esophageal carcinoma
    Wang, Wen-Ping
    Ni, Peng-Zhi
    Yang, Jin-Lin
    Wu, Jun-Chao
    Yang, Yu-Shang
    Chen, Long-Qi
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3253 - 3261
  • [46] The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer
    Kubo, Yuto
    Tanaka, Koji
    Yamasaki, Makoto
    Yamashita, Kotaro
    Makino, Tomoki
    Saito, Takuro
    Yamamoto, Kazuyoshi
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
  • [47] A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy
    Wang, Yichun
    Zhang, Li
    Ye, Dongmei
    Xia, Wanli
    Jiang, Jun
    Wang, Xiumei
    Zhang, Mingxia
    Wang, Fan
    ONCOLOGY LETTERS, 2018, 15 (03) : 4033 - 4039
  • [48] The Academic Facility Is Associated with Higher Utilization of Esophagectomy and Improved Overall Survival for Esophageal Carcinoma
    Merritt, Robert E.
    Abdel-Rasoul, Mahmoud
    Fitzgerald, Morgan
    D'Souza, Desmond M.
    Kneuertz, Peter J.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (07) : 1677 - 1689
  • [49] Survival benefit of multimodal local therapy for repeat recurrence of thoracic esophageal squamous cell carcinoma after esophagectomy
    Ninomiya, Itasu
    Okamoto, Koichi
    Fushida, Sachio
    Kinoshita, Jun
    Takamura, Hiroyuki
    Tajima, Hidehiro
    Makino, Isamu
    Miyashita, Tomoharu
    Ohta, Tetsuo
    ESOPHAGUS, 2019, 16 (01) : 107 - 113
  • [50] Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy
    Duan, Jingjing
    Deng, Ting
    Ying, Guoguang
    Huang, Dingzhi
    Zhang, Haiyang
    Zhou, Likun
    Bai, Ming
    Li, Hongli
    Yang, Huimin
    Qu, Yanjun
    Wang, Xia
    Ba, Yi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) : 336 - 343